Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine.

Pérez O, Lastre M, Lapinet J, Bracho G, Díaz M, Zayas C, Taboada C, Sierra G.

Infect Immun. 2001 Jul;69(7):4502-8.

2.

Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.

Plested JS, Ferry BL, Coull PA, Makepeace K, Lehmann AK, MacKinnon FG, Griffiths HG, Herbert MA, Richards JC, Moxon ER.

Infect Immun. 2001 May;69(5):3203-13.

3.

Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Frasa H, Benaissa-Trouw B, Tavares L, van Kessel K, Poppelier M, Kraaijeveld K, Verhoef J.

Infect Immun. 1996 Mar;64(3):775-81.

4.

Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes.

Vogel L, van Alphen L, Geluk F, Troelstra A, Martin E, Bredius R, Eijk P, Jansen H, Dankert J.

Clin Diagn Lab Immunol. 1994 Jul;1(4):394-400.

5.

Opsonic antibodies to outer membrane protein P2 of nonencapsulated Haemophilus influenza are strain specific.

Troelstra A, Vogel L, van Alphen L, Eijk P, Jansen H, Dankert J.

Infect Immun. 1994 Mar;62(3):779-84.

Supplemental Content

Support Center